Антифосфолипидный синдром - Насонов Е.Л.
ISBN 5-98216-010-5
Скачать (прямая ссылка):
7. Fort. JG, Cowchock FS, Abruzzo, JL. Smith. J.B. Aniicardiolipin antibodies in patients with rheumatic diseases. Arthritis Rheum. 1987: 30: 752—760.
8. Manoussakis MN, Tzioufas, AG, Silis MP, Range PJE, Goudevenos J, Moulsopoulos HM. High prevalence of anli-cardiolipin and other autoanlibodies in a healthy elderly population. Clin Exp Immunol 1987; 69: 557—565.
9. Petri M, Rheinschmidi M, Whiiing-OKeefe Q, Hellmann D, Corash L. The frequency of lupus aniicoagulani in systemic lupus crylhcmalosus: a study of 60 consecutive patients with activated partial thromboplaslin time. Russell viper venom lime, and aniicardiolipin antibody. Ann Int Med 1987: 106:524—531.
10. Sturfel G, Nived O, Norberg R, Thorstensson R, Krook K. Anticardiolipin antibodies in patients with systemic lupus erythemato-sus. Arthritis Rheum 1987; 30: 383—388.
11. EI-Roeiy A, Glcicher N. Definition of non-nal autoantibody levels in an apparently healthy population. Obstet. Gynecol 1988; 72: 596—602.
12. Kalunian KC, Peter JB, Middlekauf HR, Sayre J, Ando DG, Mangotich M, Hahn BH. Clinical significance of a single test for anti-car-diolipin antibodies in patients with systemic lupus eryihcmaiosus. Am J Med 1988; 85: 602—608.
13. Briley D, Coull BM, Goodnight Jr, SH. Neurological disease associated with antiphospho-lipid antibodies. Ann Neural 1989; 25: 221—227.
14. Dekzez M, Alarcon-Segovia D, Oria CV, Sanchez-Guerrero. J, Femandez-DominguezL, Gomez-Pacheco L, Ponce de Leon. S. Hemocytopenia in systemic lupus erylhemaio-sus. Relationship to antiphospholipid antibodies. J. Rheumaiol. 1989; 16: 926—930.
15. Faux JA, Byron MA, Chapel HM. Clinical relevance of specific IgG antibodies to cardiolipin. Lancet 1989; 2: 1457—1458.
16. Fields RA, Toubbeh H, Searles RP, Bankhurs A.D. The prevalence of anticardiolipin antibodies in a healthy elderly population and its association with antinuclear antibodies. J Rheumaiol 1989; 16: 623—615.
17. Lockwood. CJ, Romero R, Feinberg R.F, Clyne L.P, Cosier B.S, Bobbins J.C. The prevalence and biologic significance of lupus anticoagulant and anticardiolipin antibodies in a general obstetric population. Am J Obstet Gynecol 1989; 161: 369—373.
18. Cervera R, Font J, Lopez-Soto A, Casals F, Pallares L, Bove A, Ingelmo M, Urbano-Mirquez A. Isotype distribution of anticardiolipin antibodies in systemic lupus erylhemaiosus: prospective analysis of a series of 100 patients. Ann Rheum. Dis 1990; 49: 109—113.
19. EI-Roeiy A, Myers SA, Gleicher. N. The prevalence of autoantibodies and lupus anticoagulant in healthy pregnant women. Obstel Gynecol 1990; 75: 390.
20. Kushner MJ. Prospective study of anticardi-olipin antibodies in stroke. Stroke 1990; 21: 295—298.
21. Shi W, Krilis SA, Chong BH, Gordon S, Chesterman CN. Prevalence of lupus anticoagulani and anticardiolipin antibodies in a healthy population. Aust NZ J Med 1990; 20 (3): 23l—236.
22. Harris E.N, Spinnato. J.A. Should anticar-diolipin tests be performed in otherwise healthy pregnant women?Am. J. Obstel. Gynecol. 1991; 165 (5. pt. I): I272—I277.
23. Infanie-Rivard. C, David. M, Gauihier R, Rivard. G.E. Lupus anticoagulants, antickardi-olipin antibodies, and fetal loss. A case-control study. N. Engl J Med 1991; 325:1063—1066.
24. Out H, Bruinse HW, Chrisiiaens GC. et al. Prevalence of antiphospholipid antibodies in patients with fetal loss. Ann. Rheum. Dis. 1991; 50: 553—557.
25. Parke AL, Wilson D, Maier D. The prevalence of antiphospholipid antibodies in women with recurrent spontaneous abortion, women with successful pregnancies, and women who have never been pregnant. Arthritis Rheum. 1991; 34(10): 1231—1235.
26. Parazzini F, Acaia B, Faden D, et al. Antiphospholipid antibodies and recurrent abo-nion. Obstet Gynecol 1991; 77: 854.
SHS-OOO4.qxd 21.11.2006 16:56 Page 33
3
ГЛАВА 1. Эпидемиология антифосфолипидного синдрома
27. Perez. MC, Wilson WA, Brown HL, Scopelitis E. Anticardiolipin antibodies in unse-lectedpregnant women in relationship to fetal outcome. J Perinatal 1991; 11: 33—36.
28. Soloninka CA, Laskin CA, Wither J, Wong D, Bombardier C, Raboud J. Clinical utility and specificity of anticardiolipin antibodies. J Rheumatol 1991; 18:1849—1855.
29. The Antiphospholipid Antibodies in Stroke Study Group (APASS). Clinical, radiological, and pathological aspects of cerebrovascular disease associated with antiphospholipid antibodies. Stroke 1993; 24(12 Suppl): 20—ll23.
30. Edwards T, Thomas RD, McHugh N J. Anticardiolipin antibodies in ischaemic heart disease (letter, comment). Lancet 1993; 342(8877): 989.
31. de Jong AW, Han W, Terburg M, Molenaa JL, Herbrink P, Ho. WC. Cardiolipin antibodies and lupus anticoagulant in young patients with a cerebrovascular accident in the past. Neth J Med 1993; 42(3—4): 93—98.
32. Pattison NS, Chamley LW, McKay EJ, Liggins CC, Butler W.S. Antiphospholipid antibodies in pregnancy: prevalence and clinical associations. Br J Obster Gynaecol 1993; 100: 909—9I3.
33. Phadke KV, Phillips RA, Clarke DT, Jones M, Naish P, Carson P. Anticardiolipin antibodies in ischaemic heart disease: marker or myth? Br Heart J 1993; 69: 391—394.
